Dyslipidemia in Diabetes: Navigating a Complex Landscape for Improved Cardiovascular Outcomes.

Clin Med Insights Endocrinol Diabetes · 2026 · PMC12929832 · PMID 41743491

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significanceno p-value reported

These results are encouraging; however, they are limited by the small sample size (due to the rarity of the condition) and the borderline significance. 95 Evinacumab is currently approved by the FDA and EMA to treat HoFH.

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.